← Back to all articles

Articles · Market Video, Morning Watch

SMH vs XLP: Chips Hit a Six-Month Low the Day Staples Hit a High

Two November 5 intraday extremes, shown on separate dated ETF charts.

Published Nov 11, 2026

Watch on YouTube ↗

TL;DR

  • SMH touched a 126-session intraday low of $445.59 on November 5.
  • XLP touched a 126-session intraday high of $93.40 the same day.
  • The contrast does not prove flows between the funds.

Watch the SMH/XLP Short. See the November 11 Daily Levels for the dated chart notes.

The VanEck Semiconductor ETF (SMH) reached $445.59 intraday on November 5, its lowest intraday price in the reviewed 126-session window. The Consumer Staples Select Sector SPDR Fund (XLP) reached $93.40 intraday the same day, its highest intraday price in that window. These are intraday extremes, not closing records or proof of money flowing between the funds.

SMH daily price and volume through November 10. Its November 5 low of $445.59 was intraday; open full size for exact levels.Open chart to enlarge and pan at full size.
XLP daily price and volume through November 10. Its November 5 high of $93.40 was intraday; open full size for exact levels.Open chart to enlarge and pan at full size.

A separately sampled November 11 premarket comparison showed SMH above its November 10 regular close while XLP was lower. Premarket last sales are not completed daily candles and can change before the open. On the November 10 daily SMH chart, the next dated YTP Zones band above that close began at $518.35; it is an observed zone, not a target.

Sources: attributed TradingView daily captures through November 10 and completed-session close cross-checks. Market research only, not a recommendation to buy or sell.

Get the Sunday Recap by email

One email a week. Every issue is published on the site too, so this is only about getting it in your inbox.

Subscribing signs you up for the free YieldTerminal Sunday recap, one email a week. Educational only, not financial advice. Unsubscribe any time.

Educational commentary, not a recommendation to buy or sell anything.